Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethyl Fumarate in SSc-PAH
NCT02981082Phase 1Terminated
- Start
- Dec 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) comparing Dimethyl Fumarate with Placebo (2 arms). Primary endpoint: 6 Minute Walk Distance at 24 weeks. Started Dec 2016; status: terminated.
02
Drugs
dimethyl fumarate
03
Conditions
systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH)
Beyond the preview
Go deeper on NCT02981082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02981082.